Utilizing Stimulated Raman Scattering Microscopy To Study Intracellular Distribution of Label-Free Ponatinib in Live Cells
Open Access
- 12 December 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (5), 2028-2034
- https://doi.org/10.1021/acs.jmedchem.9b01546
Abstract
Stimulated Raman scattering (SRS) microscopy represents a powerful method for imaging label-free drug dis-tribution with high resolution. SRS was applied to image label-free ponatinib with high sensitivity and speci-ficity in live human chronic myeloid leukemia (CML) cell lines. This was achieved at biologically relevant, na-nomolar concentrations; allowing determination of ponatinib uptake and sequestration into lysosomes during the development of acquired drug resistance and an improved understanding of target engagement.Keywords
Funding Information
- Engineering and Physical Sciences Research Council (EP/L016559/1)
- Medical Research Council
- Cancer Research UK (C157/A15703, C157/A25140)
This publication has 35 references indexed in Scilit:
- Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral DrugsJournal of Medicinal Chemistry, 2018
- Imaging drug uptake by bioorthogonal stimulated Raman scattering microscopyChemical Science, 2017
- Screening out irrelevant cell-based models of diseaseNature Reviews Drug Discovery, 2016
- Stimulated Raman scattering microscopy: an emerging tool for drug discoveryChemical Society Reviews, 2016
- Vibrational spectroscopic imaging of living systems: An emerging platform for biology and medicineScience, 2015
- An analysis of the attrition of drug candidates from four major pharmaceutical companiesNature Reviews Drug Discovery, 2015
- Imaging the intracellular distribution of tyrosine kinase inhibitors in living cells with quantitative hyperspectral stimulated Raman scatteringNature Chemistry, 2014
- Clinical development success rates for investigational drugsNature Biotechnology, 2014
- Targeted agents: How to select the winners in preclinical and early clinical studies?European Journal Of Cancer, 2012
- How to improve R&D productivity: the pharmaceutical industry's grand challengeNature Reviews Drug Discovery, 2010